Russian Extreme Hypertriglyceridemia Registry
The REGGI registry is a prospective, multicenter observational registry in Russia designed to collect data on patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L). The registry aims to describe the clinical, demographic, and molecular-genetic characteristics of patients, as well as current diagno
| Condition(s) | Hypertriglyceridemia |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The REGGI registry is a prospective, multicenter observational registry in Russia designed to collect data on patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L). The registry aims to describe the clinical, demographic, and molecular-genetic characteristics of patients, as well as current diagnostic approaches and treatment patterns in real-world practice. The collected data may inform future research and support improvements in patient care. |
| Who can participate | Inclusion Criteria: * Patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L), confirmed by at least two independent measurements. * Written informed consent from the patient or legal guardian. * No age restrictions. Exclusion Criteria: * Patients whose extreme hypertriglyceridemia is caused by alcohol abuse, uncontrolled diabetes, or other medical conditions, unless extreme hypertriglyceridemia is confirmed after controlling the underlying condition. * Lack of informed consent. |
| Sex | All |
| Lead sponsor | Russian Cardiology Research and Production Center |
| Locations | Astrakhan, Russia; Chelyabinsk, Russia; Kaluga, Russia; Kazan', Russia; Moscow, Russia; Moscow, Russia |
| Start date | 2025-11-20 |
| NCT ID | NCT07508930 |
| Official listing | https://clinicaltrials.gov/study/NCT07508930 |